IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i5p1710-d328952.html
   My bibliography  Save this article

Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines

Author

Listed:
  • Leila Zarei

    (Pharmacoeconomics and Pharma Management, Health Policy Research Center, Institute of Heath, Shiraz University of Medical Sciences, Shiraz, Fars, Iran)

  • Iman Karimzadeh

    (Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran)

  • Najmeh Moradi

    (Pharmacoeconomics and Pharma Management, Health Management and Economics Research Centre, Iran University of Medical Sciences, Tehran, Iran)

  • Payam Peymani

    (Pharmacoepidemiology, Health Policy Research Center, Institute of Heath, Shiraz University of Medical Sciences, Shiraz, Fars, Iran
    Department of Clinical Pharmacology & Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland)

  • Sara Asadi

    (Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran)

  • Zaheer-Ud-Din Babar

    (Medicines and Healthcare, Department of Pharmacy, University of Huddersfield, Queensgate, HD1 3DH Huddersfield, UK)

Abstract

The out-of-pocket payments for prescription medications can impose a financial burden on patients from low- and middle- incomes and who suffer from chronic diseases. The present study aims at evaluating the affordability of cardiovascular disease (CVD) medication in Iran. This includes measuring affordability through World Health Organization/Health Action International (WHO/HAI) methodology. In this method, affordability is characterized as the number of days’ wages of the lowest-paid unskilled government worker. The different medication therapy scenarios are defined in mono-and combination therapy approaches. This method adds on to WHO/HAI methodology to discover new approaches to affordability assessments. The results show the differences in the medicines affordability when different approaches are used in mono-and combination therapy between 6 main sub-therapeutic groups of CVD. It indicates the medicine affordability is not a static concept and it changes dynamically between CVD therapeutic subgroups when it used alone or in combination with other medicines regarding patients’ characteristics and medical conditions. Hypertension and anti-arrhythmia therapeutic groups had the most non-affordability and hyperlipidemia had the most affordable medicines. Therefore, affordability can be considered as a dynamic concept, which not only affected by the medicine price but significantly affected by a patient’s characteristics, the number of medical conditions, and insurance coverage.

Suggested Citation

  • Leila Zarei & Iman Karimzadeh & Najmeh Moradi & Payam Peymani & Sara Asadi & Zaheer-Ud-Din Babar, 2020. "Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines," IJERPH, MDPI, vol. 17(5), pages 1-19, March.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:5:p:1710-:d:328952
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/5/1710/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/5/1710/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Mohammadreza Amiresmaili & Zahra Emrani, 2019. "Investigating the exposure of Iranian households to catastrophic health expenditure due to the need to purchase medicines," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-11, April.
    2. Caijun Yang & Shuchen Hu & Yanbing Zhu & Wenwen Zhu & Zongjie Li & Yu Fang, 2019. "Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-13, October.
    3. Zaheer Ud Din Babar & Mohamed Izham Mohamed Ibrahim & Harpal Singh & Nadeem Irfan Bukahri & Andrew Creese, 2007. "Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia," PLOS Medicine, Public Library of Science, vol. 4(3), pages 1-10, March.
    4. Margaret Ewen & Marjolein Zweekhorst & Barbara Regeer & Richard Laing, 2017. "Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-13, February.
    5. Jelena Arsenijevic & Milena Pavlova & Bernd Rechel & Wim Groot, 2016. "Catastrophic Health Care Expenditure among Older People with Chronic Diseases in 15 European Countries," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-18, July.
    6. Laurens M Niëns & Alexandra Cameron & Ellen Van de Poel & Margaret Ewen & Werner B F Brouwer & Richard Laing, 2010. "Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World," PLOS Medicine, Public Library of Science, vol. 7(8), pages 1-8, August.
    7. Niëns, L.M. & Brouwer, W.B.F., 2013. "Measuring the affordability of medicines: Importance and challenges," Health Policy, Elsevier, vol. 112(1), pages 45-52.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Xiao Wang & Yu Fang & Shimin Yang & Minghuan Jiang & Kangkang Yan & Lina Wu & Bing Lv & Qian Shen, 2014. "Access to Paediatric Essential Medicines: A Survey of Prices, Availability, Affordability and Price Components in Shaanxi Province, China," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-7, March.
    2. Sabine Vogler, 2019. "Fair prices for medicines? Exploring competent authorities’ and public payers’ preferences on pharmaceutical policies," Empirica, Springer;Austrian Institute for Economic Research;Austrian Economic Association, vol. 46(3), pages 443-469, August.
    3. Krizzia Lambojon & Jie Chang & Amna Saeed & Khezar Hayat & Pengchao Li & Minghuan Jiang & Naveel Atif & Gebrehaweria Kassa Desalegn & Faiz Ullah Khan & Yu Fang, 2020. "Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines," IJERPH, MDPI, vol. 17(14), pages 1-15, July.
    4. Chong, Chee Ping & Hassali, Mohamed Azmi & Bahari, Mohd Baidi & Shafie, Asrul Akmal, 2010. "Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia," Health Policy, Elsevier, vol. 94(1), pages 68-75, January.
    5. Andrea Hannah Kaiser & Lindsey Hehman & Birger Carl Forsberg & Warren Mukelabai Simangolwa & Jesper Sundewall, 2019. "Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-18, December.
    6. Zhu, Minmin & Dib, Hassan H. & Zhang, Xinping & Tang, Shengchun & Liu, Liqun, 2008. "The influence of health insurance towards accessing essential medicines: The experience from Shenzhen labor health insurance," Health Policy, Elsevier, vol. 88(2-3), pages 371-380, December.
    7. Amna Saeed & Hamid Saeed & Zikria Saleem & Yu Fang & Zaheer-Ud-Din Babar, 2019. "Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-16, April.
    8. Varun Karamshetty & Harwin De Vries & Luk N. Van Wassenhove & Sarah Dewilde & Warnyta Minnaard & Dennis Ongarora & Kennedy Abuga & Prashant Yadav, 2022. "Inventory Management Practices in Private Healthcare Facilities in Nairobi County," Production and Operations Management, Production and Operations Management Society, vol. 31(2), pages 828-846, February.
    9. Niëns, L.M. & Brouwer, W.B.F., 2013. "Measuring the affordability of medicines: Importance and challenges," Health Policy, Elsevier, vol. 112(1), pages 45-52.
    10. Raúl Pozo-Rubio & Román Mínguez-Salido & Isabel Pardo-García & Francisco Escribano-Sotos, 2019. "Catastrophic long-term care expenditure: associated socio-demographic and economic factors," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 691-701, July.
    11. Raúl Pozo-Rubio & Marta Ortega-Ortega, 2022. "Sociodemographic and health factors associated with the risk of financial catastrophe when informal care for patients with haematological neoplasms is replaced by formal care," Health Economics Review, Springer, vol. 12(1), pages 1-12, December.
    12. Samuel López-López & Raúl Pozo-Rubio & Marta Ortega-Ortega & Francisco Escribano-Sotos, 2022. "Catastrophic household expenditure associated with out-of-pocket payments for dental healthcare in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(7), pages 1187-1201, September.
    13. Tavares, Lara Patrício & Zantomio, Francesca, 2017. "Inequity in healthcare use among older people after 2008: The case of southern European countries," Health Policy, Elsevier, vol. 121(10), pages 1063-1071.
    14. Mari Armstrong-Hough & Sandeep P Kishore & Sarah Byakika & Gerald Mutungi & Marcella Nunez-Smith & Jeremy I Schwartz, 2018. "Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-12, February.
    15. Daniela Moye-Holz & S. Vogler, 2022. "Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 67-77, January.
    16. Surachat Ngorsuraches & Kanokkan Chaiyakan, 2015. "Equitable Prices of Single-Source Drugs in Thailand," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 389-397, August.
    17. Minghuan Jiang & Shimin Yang & Kangkang Yan & Jun Liu & Jun Zhao & Yu Fang, 2013. "Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-8, August.
    18. Veronika Kočiš Krůtilová, 2021. "The out‐of‐pocket medication burden: Which health problems impact the Czech population aged 50+?," International Journal of Health Planning and Management, Wiley Blackwell, vol. 36(6), pages 2129-2144, November.
    19. Indrani Gupta & Arjun Roy, 2021. "Including musculoskeletal diseases in the health policy agenda in India Evidence on burden and economic impact on Indian households," IEG Working Papers 432, Institute of Economic Growth.
    20. Kyriopoulos, Ilias & Nikoloski, Zlatko & Mossialos, Elias, 2021. "Financial protection in health among the middle-aged and elderly: Evidence from the Greek economic recession," Health Policy, Elsevier, vol. 125(9), pages 1256-1266.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:5:p:1710-:d:328952. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.